- Home
- OMH vs PPBT Comparison
OMH vs PPBT Comparison
Compare OMH & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- PPBT
- Stock Information
- Founded
- OMH 2015
- PPBT 2010
- Country
- OMH Singapore
- PPBT Israel
- Employees
- OMH N/A
- PPBT N/A
- Industry
- OMH Real Estate
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- PPBT Health Care
- Exchange
- OMH Nasdaq
- PPBT Nasdaq
- Market Cap
- OMH 13.6M
- PPBT 6.3M
- IPO Year
- OMH 2023
- PPBT N/A
- Fundamental
- Price
- OMH $1.45
- PPBT $2.35
- Analyst Decision
- OMH Hold
- PPBT Strong Buy
- Analyst Count
- OMH 1
- PPBT 1
- Target Price
- OMH N/A
- PPBT $33.00
- AVG Volume (30 Days)
- OMH 5.5M
- PPBT 26.2K
- Earning Date
- OMH 07-11-2025
- PPBT 08-15-2025
- Dividend Yield
- OMH N/A
- PPBT N/A
- EPS Growth
- OMH N/A
- PPBT N/A
- EPS
- OMH N/A
- PPBT N/A
- Revenue
- OMH $7,976,578.00
- PPBT N/A
- Revenue This Year
- OMH $28.40
- PPBT N/A
- Revenue Next Year
- OMH $23.07
- PPBT N/A
- P/E Ratio
- OMH N/A
- PPBT N/A
- Revenue Growth
- OMH 117.53
- PPBT N/A
- 52 Week Low
- OMH $0.59
- PPBT $2.00
- 52 Week High
- OMH $6.20
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- OMH 46.11
- PPBT 42.60
- Support Level
- OMH $1.45
- PPBT $2.25
- Resistance Level
- OMH $1.59
- PPBT $2.45
- Average True Range (ATR)
- OMH 0.40
- PPBT 0.13
- MACD
- OMH 0.02
- PPBT -0.02
- Stochastic Oscillator
- OMH 35.76
- PPBT 21.11
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.